The Center for Chemical Genomics (CCG) defines chemical genomics as the use of specific chemical inhibitors or activators to dissect the biological function of genes and gene products. These chemicals include small molecules, peptides, natural product extracts or synthetically modified RNA. The CCG uses automated high-throughput screening technology to perform functional chemical genomic screens on biochemical targets, cellular processes and in intact organisms.
The Center for Chemical Genomics wishes to thank the following sponsors for their generous support: Life Sciences Institute; Dept. of Pathology; Office of the Dean, School of Medicine; Dept. of Internal Medicine; Michigan Diabetes Research Training Center, Michigan Institute for Clinical and Health Research; Michigan Center for Translational Pathology; UM Comprehensive Cancer Center; Medical School Endowment for the Basic Sciences (EBS); Office of the Vice President for Research; the Medical School Tech Transfer Fund; Thermo Fisher Scientific, Inc.; The Gregory Alan Margolies Fund for Cancer Research and Cayman Chemical, Inc.
Last updated October, 2009
